Résumé
The overall age-standardized SARS-CoV-2 IgG seroprevalence against spike and nucleocapsid proteins was 71.57% in Guinea and 74.71% in Cameroon after successive COVID-19 waves, including the Omicron wave from early 2022. Seroprevalence increased with age categories reaching 84% among persons >40 years.